Green Thumb Industries (GTBIF) 10-Q 6 Aug 24 2024 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2024	Aug. 01, 2024
Document Information [Line Items]
Document Type	10-Q
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Entity File Number	000-56132
Entity Registrant Name	GREEN THUMB INDUSTRIES INC.
Entity Central Index Key	0001795139
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Address, Address Line One	325 West Huron Street
Entity Address, Address Line Two	Suite 700
Entity Address, City or Town	Chicago
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60654
Entity Tax Identification Number	98-1437430
City Area Code	312
Local Phone Number	471-6720
Entity Incorporation, State or Country Code	A1
Document Quarterly Report	true
Document Transition Report	false
Subordinate Voting Shares [Member]
Document Information [Line Items]
Title of 12(g) Security	Subordinate Voting Shares
Entity Common Stock, Shares Outstanding		211,380,808
Super Voting Shares [Member]
Document Information [Line Items]
Title of 12(g) Security	Super Voting Shares
Entity Common Stock, Shares Outstanding		206,690
Multiple Voting Shares [Member]
Document Information [Line Items]
Title of 12(g) Security	Multiple Voting Shares
Entity Common Stock, Shares Outstanding		37,683

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current Assets:
Cash and Cash Equivalents	$ 196,142	$ 161,634
Accounts Receivable, Net	49,335	42,975
Income Tax Receivable	3,486	0
Inventories, Net	130,530	112,970
Prepaid Expenses	19,497	19,801
Other Current Assets	4,812	5,382
Total Current Assets	403,802	342,762
Property and Equipment, Net	694,039	687,106
Right of Use Assets, Net	247,533	238,369
Investments	61,412	64,361
Investment in Associates	23,484	24,942
Note Receivable	3,550	550
Intangible Assets, Net	513,434	538,678
Goodwill	589,691	589,691
Deferred Tax Assets	1,041	1,041
Deposits and Other Assets	2,568	2,557
TOTAL ASSETS	2,540,554	2,490,057
Current Liabilities:
Accounts Payable	29,433	24,495
Accrued Liabilities	62,776	59,552
Compensation Payable	12,917	16,005
Current Portion of Notes Payable	227,265	2,996
Current Portion of Lease Liabilities	12,853	12,297
Income Tax Payable	25,335	10,705
Total Current Liabilities	370,579	126,050
Long-Term Liabilities:
Lease Liabilities, Net of Current Portion	261,031	249,464
Notes Payable, Net of Current Portion and Debt Discount	82,478	305,527
Contingent Consideration Payable	0	33,250
Deferred Income Taxes	72,510	72,510
TOTAL LIABILITIES	786,598	786,801
COMMITMENTS AND CONTINGENCIES
SHARE HOLDERS' EQUITY
Share Capital	1,742,784	1,703,852
Contributed (Deficit) Surplus	(31,865)	7,871
Deferred Share Issuances	12,973	12,973
Accumulated Earnings (Deficit)	29,970	(21,818)
Equity of Green Thumb Industries Inc.	1,753,862	1,702,878
Noncontrolling interests	94	378
TOTAL SHAREHOLDERS' EQUITY	1,753,956	1,703,256
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 2,540,554	$ 2,490,057

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Subordinate Voting Shares [Member]
Common Stock, Shares Authorized	Unlimited	Unlimited
Common Stock, Shares, Issued	211,129,419	209,871,792
Common Stock, Shares, Outstanding	211,129,419	209,871,792
Multiple Voting Shares [Member]
Common Stock, Shares Authorized	Unlimited	Unlimited
Common Stock, Shares, Issued	37,683	38,531
Common Stock, Shares, Outstanding	37,683	38,531
Super Voting Shares [Member]
Common Stock, Shares Authorized	Unlimited	Unlimited
Common Stock, Shares, Issued	206,690	216,690
Common Stock, Shares, Outstanding	206,690	216,690

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Revenues, net of discounts	$ 280,147	$ 252,388	$ 555,953	$ 500,924
Cost of Goods Sold	(129,627)	(127,108)	(260,504)	(250,923)
Gross Profit	150,520	125,280	295,449	250,001
Expenses:
Selling, General, and Administrative	96,500	84,217	170,758	164,736
Total Expenses	96,500	84,217	170,758	164,736
Income From Operations	54,020	41,063	124,691	85,265
Other Income (Expense):
Other Income (Expense), Net	2,464	(270)	701	654
Interest Income, net	2,314	1,531	4,417	3,262
Interest Expense, net	(5,981)	(2,869)	(13,495)	(6,685)
Total Other Expense	(1,203)	(1,608)	(8,377)	(2,769)
Income Before Provision for Income Taxes And Non-Controlling Interest	52,817	39,455	116,314	82,496
Provision For Income Taxes	31,899	25,765	64,048	59,401
Net Income Before Non-Controlling Interest	20,918	13,690	52,266	23,095
Net Income Attributable to Non-Controlling Interest	206	290	478	556
Net Income Attributable To Green Thumb Industries Inc.	$ 20,712	$ 13,400	$ 51,788	$ 22,539
Net Income per share - basic	$ 0.09	$ 0.05	$ 0.22	$ 0.09
Net Income per share - diluted	$ 0.09	$ 0.05	$ 0.22	$ 0.09
Weighted average number of shares outstanding - basic	237,416,373	238,000,135	237,083,912	237,700,856
Weighted average number of shares outstanding - diluted	240,137,922	238,423,288	240,768,497	239,455,964

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Share Capital [Member]	Contributed Surplus (Deficit) [Member]	Deferred Share Issuance [Member]	Accumulated Earnings (Deficit) [Member]	Non-Controlling Interest [Member]
Beginning balance at Dec. 31, 2022	$ 1,665,432	$ 1,663,557	$ 23,233	$ 36,211	$ (58,085)	$ 516
Issuance of deferred shares		20,454		(20,454)
Distribution of Contingent Consideration	6,070	6,070
Indemnification of deferred shares associated with post acquisition costs	(2,784)			(2,784)
Exercise of options and RSUs	916	3,348	(2,432)
Stock-based compensation	13,620		13,620
Distributions to limited liability company unit holders	(533)					(533)
Repurchase of Subordinate Voting Shares	0
Net income	23,095				22,539	556
Ending balance at Jun. 30, 2023	1,705,816	1,693,429	34,421	12,973	(35,546)	539
Beginning balance at Mar. 31, 2023	1,681,146	1,683,671	28,959	17,105	(48,946)	357
Issuance of deferred shares		1,348		(1,348)
Distribution of Contingent Consideration	6,070	6,070
Indemnification of deferred shares associated with post acquisition costs	(2,784)			(2,784)
Exercise of options and RSUs	421	2,340	(1,919)
Stock-based compensation	7,381		7,381
Distributions to limited liability company unit holders	(108)					(108)
Net income	13,690				13,400	290
Ending balance at Jun. 30, 2023	1,705,816	1,693,429	34,421	12,973	(35,546)	539
Beginning balance at Dec. 31, 2023	1,703,256	1,703,852	7,871	12,973	(21,818)	378
Distribution of Contingent Consideration	17,259	17,259
Exercise of options and RSUs	5,938	10,789	(4,851)
Stock-based compensation	15,356		15,356
Options exercised through net share settlement	(5,909)	10,884	(16,793)
Distributions to limited liability company unit holders	(762)					(762)
Repurchase of Subordinate Voting Shares	(33,448)		(33,448)
Net income	52,266				51,788	478
Ending balance at Jun. 30, 2024	1,753,956	1,742,784	(31,865)	12,973	29,970	94
Beginning balance at Mar. 31, 2024	1,747,130	1,727,584	(2,816)	12,973	9,258	131
Exercise of options and RSUs	2,630	5,157	(2,527)
Stock-based compensation	8,866		8,866
Options exercised through net share settlement	(5,455)	10,043	(15,498)
Distributions to limited liability company unit holders	(243)					(243)
Repurchase of Subordinate Voting Shares	(19,890)		(19,890)
Net income	20,918				20,712	206
Ending balance at Jun. 30, 2024	$ 1,753,956	$ 1,742,784	$ (31,865)	$ 12,973	$ 29,970	$ 94

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
CASH FLOW FROM OPERATING ACTIVITIES
Net Income (Loss)	$ 51,788	$ 22,539
Net income attributable to non-controlling interest	478	556
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	55,760	47,735
Amortization of operating lease assets	24,676	24,368
Loss on disposal of property and equipment	875	1,951
Impairment of long-lived property and equipment		285
Loss on equity method investments	1,100	750
Loss from lease modification	219	0
Stock based compensation	15,356	13,620
(Increase) decrease in fair value of investments	(334)	928
Gain on settlement of contingent consideration	(15,991)	0
Increase in fair value of contingent consideration	0	2,150
Decrease in fair value of warrants	(1,534)	(2,263)
Gain on indemnification of deferred shares associated with post acquisition costs.	0	(2,784)
Amortization of debt discount	2,853	4,762
Changes in operating assets and liabilities:
Accounts receivable, net	(6,359)	(8,265)
Inventories, net	(17,561)	(9,097)
Prepaid expenses and other current assets	874	(3,285)
Deposits and other assets	(10)	676
Accounts payable	4,938	9,071
Accrued liabilities	(2,164)	3,365
Operating lease liabilities	(21,934)	(21,589)
Income tax receivable and payable, net	11,144	7,555
NET CASH PROVIDED BY OPERATING ACTIVITIES	104,174	93,028
CASH FLOW FROM INVESTING ACTIVITIES
Purchases of property and equipment	(34,963)	(129,392)
Proceeds from disposal of property and equipment	0	319
Investments in securities and associates	(5,608)	(2,800)
Proceeds from equity investments and notes receivable	6,248	331
NET CASH USED IN INVESTING ACTIVITIES	(34,323)	(131,542)
CASH FLOW FROM FINANCING ACTIVITIES
Distributions to limited liability company unit holders	(762)	(533)
Repurchase of Subordinate Voting Shares	(33,448)	0
Payments for taxes related to net share settlement of equity awards	(5,438)	0
Proceeds from exercise of options and warrants	5,938	916
Proceeds from issuance of notes payable	0	10,134
Principal repayment of notes payable	(1,633)	(659)
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES	(35,343)	9,858
CASH, CASH EQUIVALENTS :
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	34,508	(28,656)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH BEGINNING OF PERIOD	161,634	177,682
CASH, CASH EQUIVALENTS AND RESTRICTED CASH END OF PERIOD	196,142	149,026
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest paid	10,975	10,086
NONCASH INVESTING AND FINANCING ACTIVITIES
Accrued capital expenditures	3,358	12,630
Noncash increase in right of use asset	(10,333)	(3,928)
Noncash increase in lease liability	10,333	3,928
Issuance of shares associated with contingent consideration	17,259	6,070
Deferred share distributions	$ 0	$ (20,454)

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 20,712	$ 13,400	$ 51,788	$ 22,539

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Overview and Basis of Presentat

Overview and Basis of Presentation	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Overview and Basis of Presentation	1. Overview and Basis of Presentation (a) Description of Business Green Thumb Industries Inc. (“Green Thumb,” the “Company,” “we” or “us”), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while being committed to community and sustainable, profitable growth. Green Thumb owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM, to third-party retail stores across the United States as well as to Green Thumb owned retail locations. The Company also owns and operates retail cannabis stores that include a national chain named RISE Dispensaries, and sell our products and third-party products. As of June 30, 2024, Green Thumb has revenue in fourteen markets (California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia), employs approximately 4,500 people and serves millions of patients and customers annually. The Company’s registered office is located at 250 Howe Street, 20 th Floor, Vancouver, British Columbia, V6C 3R8. The Company’s U.S. headquarters are at 325 W. Huron St., Suite 700, Chicago, IL 60654. (b) Basis of Presentation The accompanying unaudited interim condensed consolidated financial statements include the accounts of Green Thumb and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the rules and regulations of the U.S. Securities & Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and, accordingly, certain information, footnotes and disclosures normally included in the annual financial statements, prepared in accordance with GAAP, have been condensed or omitted in accordance with SEC rules and regulations. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”). In the opinion of management, the financial data presented includes all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented. Certain previously reported amounts have been reclassified between line items to conform to the current period presentation. Results of interim periods should not be considered indicative of the results for the full year. These unaudited interim condensed consolidated financial statements include estimates and assumptions of management that affect the amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from these estimates. (c) Significant Accounting Policies There have been no changes to the Company’s significant accounting policies as described in Note 2 to the Company's Consolidated Financial Statements included in the 2023 Form 10-K. (d) Earnings per Share Basic earnings per share is calculated using the treasury stock method, by dividing the net earnings attributable to shareholders by the weighted average number of common shares outstanding during each of the periods presented. Contingently issuable shares (including shares held in escrow) are not considered outstanding common shares and consequently are not included in the earnings per share calculation. Diluted earnings per share is calculated using the treasury stock method by adjusting the weighted average number of common shares outstanding to assume conversion of all dilutive potential common shares. The Company has three categories of potentially dilutive common share equivalents: restricted stock units, stock options and warrants. As of June 30, 2024, the Company had 9,196,881 options, 4,665,523 restricted stock units and 2,128,022 warrants outstanding. As of June 30, 2023, the Company had 10,874,051 options, 3,453,460 restricted stock units and 3,734,555 warrants outstanding. 1. Overview and Basis of Presentation (Continued) (d) Earnings per Share ( Continued ) In order to determine diluted earnings per share, it is assumed that any proceeds from the vesting of dilutive unvested restricted stock units, or exercise of unvested stock options and warrants would be used to repurchase common shares at the average market price during the period. Under the treasury stock method, the diluted earnings per share calculation excludes any potential conversion of stock options and convertible debt that would increase earnings per share or decrease loss per share. For the three months ended June 30, 2024, the computation of diluted earnings per share included 1,632,323 options, 971,792 restricted stock units, and 117,434 warrants. For the six months ended June 30, 2024, the computation of diluted earnings per share included 1,625,478 options, 1,939,848 restricted stock units, and 119,259 warrants. For the three months ended June 30, 2023, the computation of diluted earnings per share included 135,894 options and 287,259 restricted stock units. For the six months ended June 30, 2023, the computation of diluted earnings per share included 167,191 options and 1,587,917 restricted stock units. There were no dilutive warrants during the three and six months ended June 30, 2023 as the strike price was greater than the average stock price for the period. For the three and six months ended June 30, 2024, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 896,810 and 978,895 , respectively. For the three and six months ended June 30, 2023 , the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 3,399,518 and 3,473,866 , respectively. (e) Recently Issued Accounting Standards (i) In November 2023, the FASB issued Accounting Standards Update ( “ ASU”) No. 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures , to provide enhanced segment disclosures. The standard will require disclosures about significant segment expense categories and amounts for each reportable segment, for all periods presented. Additionally, the standard requires public entities to disclose the title and position of the Chief Operating Decision Maker ( “ CODM”) in the consolidated financial statements. These enhanced disclosures are required for all entities on an interim and annual basis, effective for fiscal years beginning after December 15, 2023, and interim periods within annual periods beginning after December 15, 2024. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements. (ii) In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , which is intended to provide enhancements to annual income tax disclosures. The standard will require more detailed information in the rate reconciliation table and for income taxes paid, among other enhancements. The standard is effective for years beginning after December 15, 2024 and early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements. The Company reviews recently issued accounting standards on a quarterly basis and has determined there are no standards yet to be adopted which are relevant to the business for disclosure.

Inventories

Inventories	6 Months Ended
	Jun. 30, 2024
Inventory Disclosure [Abstract]
Inventories	2. INVENTORIES The Company’s inventories include the following at June 30, 2024 and December 31, 2023: June 30, 2024 December 31, 2023 (in thousands) Raw Material $ 2,205 $ 1,547 Packaging and Miscellaneous 11,021 10,661 Work in Process 51,219 47,029 Finished Goods 70,320 57,631 Reserve for Obsolete Inventory ( 4,235 ) ( 3,898 ) Total Inventories, Net $ 130,530 $ 112,970

Property and Equipment

Property and Equipment	6 Months Ended
	Jun. 30, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment	3. PROPERTY AND EQUIPMENT At June 30, 2024 and December 31, 2023, property and equipment consisted of the following: June 30, 2024 December 31, 2023 (in thousands) Buildings and Improvements $ 354,195 $ 353,912 Equipment, Computers and Furniture 182,041 171,522 Leasehold Improvements 222,073 200,232 Land Improvements 1,168 1,046 Capitalized Interest 31,603 30,817 Total Property and Equipment 791,080 757,529 Less: Accumulated Depreciation ( 157,168 ) ( 127,290 ) Property and Equipment, net 633,912 630,239 Land 33,725 33,725 Assets Under Construction 26,402 23,142 Property and Equipment, net $ 694,039 $ 687,106 Assets under construction represent costs associated with construction projects on cultivation and production facilities and retail stores as well as costs associated with internal-use software not yet placed in service. Depreciation expense for the three and six months ended June 30, 2024 totaled $ 15,412 thousand and $ 30,516 thousand, respectively, of which $ 9,930 thousand and $ 19,723 thousand, respectively, is included in cost of goods sold. Depreciation expense for the three and six months ended June 30, 2023 totaled $ 11,490 thousand and $ 22,381 thousand respectively, of which $ 7,694 thousand and $ 15,050 thousand, respectively, is included in cost of goods sold.

Intangible Assets And Goodwill

Intangible Assets And Goodwill	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	4. INTANGIBLE ASSETS AND GOODWILL (a) Intangible Assets Intangible assets are recorded at cost less accumulated amortization and impairment losses. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Amortization of definite life intangibles is provided on a straight-line basis over their estimated useful lives. The estimated useful lives, residual values, and amortization methods are reviewed at each year end, and any changes in estimates are accounted for prospectively. At June 30, 2024 and December 31, 2023, intangible assets consisted of the following: June 30, 2024 December 31, 2023 Gross Carrying Amount Accumulated Amortization Net Book Value Gross Carrying Amount Accumulated Amortization Net Book Value (in thousands) (in thousands) Licenses and Permits $ 660,716 $ 179,813 $ 480,903 $ 660,716 $ 157,764 $ 502,952 Trademarks 41,511 14,746 26,765 41,511 13,378 28,133 Customer Relationships 24,438 18,672 5,766 24,438 16,927 7,511 Non-Competition Agreements 2,565 2,565 — 2,565 2,483 82 Total Intangible Assets $ 729,230 $ 215,796 $ 513,434 $ 729,230 $ 190,552 $ 538,678 The Company recorded amortization expense for the three and six months ended June 30, 2024 of $ 12,573 thousand and $ 25,244 thousand, respectively. The Company recorded amortization expense for the three and six months ended June 30, 2023 of $ 12,744 thousand and $ 25,354 thousand, respectively. As of June 30, 2024 and December 31, 2023 , intangible assets are carried net of accumulated impairment losses of $ 31,131 thousand as of each period then ended. The following table outlines the estimated annual amortization expense related to intangible assets as of June 30, 2024: Estimated Year Ending December 31, (in thousands) Remainder of 2024 $ 25,148 2025 50,294 2026 47,332 2027 46,803 2028 46,803 2029 and Thereafter 297,054 $ 513,434 As of June 30, 2024 , the weighted average amortization period remaining for intangible assets was 10.91 years. (b) Goodwill At June 30, 2024 and December 31, 2023 the balances of goodwill, by segment, consisted of the following: June 30, 2024 December 31, 2023 (in thousands) Retail $ 273,802 $ 273,802 Consumer Packaged Goods 315,889 315,889 Total $ 589,691 $ 589,691 Goodwill is recognized net of accumulated impairment losses of $ 57,372 thousand as of June 30, 2024 and December 31, 2023. During the three and six months ended June 30, 2024 and 2023 , there were no goodwill impairment charges recognized by the Company in the unaudited interim condensed consolidated statements of operations.

Investments

Investments	6 Months Ended
	Jun. 30, 2024
Investments [Abstract]
Investments	5. INVESTMENTS As of June 30, 2024 and December 31, 2023, the Company held various equity interests in cannabis-related companies as well as investments in note(s) receivable instruments that had a combined fair value of $ 61,412 thousand and $ 64,361 thousand, respectively. The Company measures its investments that do not have readily determinable fair value at cost minus impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The Company performs an assessment on a quarterly basis to determine whether triggering events for impairment exist and to identify any observable price changes. The following table summarizes the changes in the Company’s investments during the six months ended June 30, 2024 and year ended December 31, 2023: June 30, 2024 December 31, 2023 (in thousands) Beginning $ 64,361 $ 74,169 Additions 2,965 8,200 Disposals ( 6,248 ) ( 498 ) Fair value adjustment 334 ( 17,460 ) Transfers and other — ( 50 ) Ending $ 61,412 $ 64,361 The following table summarizes the change in fair value associated with the Company's equity investments and notes receivable instruments recorded during the three and six months ended June 30, 2024 and 2023. Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (in thousands) Equity Investments $ ( 481 ) $ ( 655 ) $ 158 $ ( 1,134 ) Notes Receivable Instruments 9 — 9 — Accrued Interest on Notes Receivable Instruments 84 78 167 206 Net fair value gains (losses) $ ( 388 ) $ ( 577 ) $ 334 $ ( 928 ) (a) Equity Investments As of June 30, 2024 and December 31, 2023, the Company held equity investments in publicly traded entities which have readily determinable fair values, which are classified as Level 1 investments of $ 507 thousand and $ 2,001 thousand, respectively. During the three and six months ended June 30, 2024 , the Company recorded (losses) gains on the change in fair value of such investments of $ ( 481 ) thousand and $ 158 thousand, respectively, within other income (expense) on the unaudited interim condensed consolidated statement of operations. During the three and six months ended June 30, 2023, the Company recorded net losses on the change in fair value of such investments of $ 655 thousand and $ 1,134 thousand, respectively, within other income (expense) on the unaudited interim condensed consolidated statement of operations. During the six months ended June 30, 2024 and 2023, the Company received proceeds from the sale of such investments of $ 1,652 thousand and $ 31 thousand, respectively. As of June 30, 2024 and December 31, 2023, the Company held equity investments in privately held entities that did not have readily determinable fair values, which are classified as Level 3 investments, of $ 25,953 thousand as of each period end. For the three and six months ended June 30, 2024 and 2023, there were no gains or losses on the change in fair value of such investments. There were no sales of these investments during these periods. These investments are classified as trading securities and are included within investments on the Company's unaudited interim condensed consolidated balance sheets. See Note 13 - Fair Value Measurements for additional details. 5. INVESTMENTS (Continued) (a) Equity Investments (Continued) Unrealized (losses) gains associated with the Company's equity investments recorded during the three and six months ended June 30, 2024 were $ ( 253 ) thousand and $ 319 thousand, respectively. Unrealized (losses) gains associated with the Company's equity investments recorded during the three and six months ended June 30, 2023 were $( 653 ) thousand and $ 1,996 thousand, respectively. (b) Notes Receivable Instruments As of June 30, 2024 and December 31, 2023, the Company held note receivable instruments, which were classified as a Level 1 investment as they represent public debt of a publicly traded entity, and had a fair value of $ 24,188 thousand and $ 22,214 thousand, respectively . During the three and six months ended June 30, 2024, the Company recorded fair value adjustments of $ 9 thousand on these instruments. There were no gains (losses) recognized on these investments during the three and six months ended June 30, 2023. The notes receivable had a stated interest rate of 13 % and a maturity date of April 29, 2025 . The notes did not contain any conversion features. As of June 30, 2024 and December 31, 2023, the Company held note receivable instruments, which were classified as Level 3 investments as they represent loans provided to privately held entities that do not have readily determinable fair values. The note receivable instruments had a combined fair value of $ 10,764 thousand and $ 14,193 thousand, respectively, with stated interest ranging between 2.7% - 10 % and terms between twelve months to five years . The combined fair value of these notes receivable instruments includes the initial investment cost and combined contractual accrued interest of $ 84 thousand and $ 167 thousand for the three and six months ended June 30, 2024, respectively, and $ 78 thousand and $ 206 thousand for the three and six months ended June 30, 2023, respectively. The accrued interest is recorded within interest income on the unaudited interim condensed consolidated statements of operations. On January 9, 2024, one of the Company's privately held note receivable instruments matured. As a result, the Company received the principal amount of $ 4,000 thousand along with the accrued interest of $ 605 thousand on such date. These notes receivable instruments are classified as trading securities and are included within investments on the Company's unaudited interim condensed consolidated balance sheets. See Note 13 - Fair Value Measurements for additional details.

Leases

Leases	6 Months Ended
	Jun. 30, 2024
Leases [Abstract]
Leases	6. LEASES (a) Operating Leases The Company has operating leases for its retail stores, processing and cultivation facilities and corporate office spaces. Operating lease right-of-use assets and operating lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. All real estate leases are recorded on the balance sheet. Equipment and other non-real estate leases with an initial term of twelve months or less are not recorded on the balance sheet. Lease agreements for some locations provide for rent escalations and renewal options. Certain real estate leases require payment for fixed and variable non-lease components, such as taxes, insurance and maintenance. The Company accounts for each real estate lease and the related non-lease components together as a single component. The Company determines if an arrangement is a lease at inception. The Company must consider whether the contract conveys the right to control the use of an identified asset. Certain arrangements require significant judgment to determine if an asset is specified in the contract and if the Company directs how and for what purpose the asset is used during the term of the contract. For three and six months ended June 30, 2024, the Company recorded operating lease expense of $ 12,425 thousand and $ 24,676 thousand, respectively compared to operating lease expense of $ 12,146 thousand and $ 24,368 thousand for three and six months ended June 30, 2023, respectively. Other information related to operating leases as of June 30, 2024 and December 31, 2023 were as follows: June 30, 2024 December 31, 2023 Weighted average remaining lease term (years) 11.19 11.75 Weighted average discount rate 12.29 % 12.40 % Maturities of lease liabilities for operating leases as of June 30, 2024 were as follows: Maturities of Lease Liability Year Ending December 31, Third-Party Related Party Total (in thousands) Remainder of 2024 $ 22,626 $ 292 $ 22,918 2025 44,893 592 45,485 2026 45,102 603 45,705 2027 45,622 572 46,194 2028 44,898 364 45,262 2029 and Thereafter 329,894 1,364 331,258 Total Lease Payments 533,035 3,787 536,822 Less: Interest ( 261,707 ) ( 1,231 ) ( 262,938 ) Present Value of Lease Liability $ 271,328 $ 2,556 $ 273,884 (b) Related Party Operating Leases The Company has leasing arrangements that are related party transactions, including for certain facilities in Maryland, Massachusetts and Nevada. Wendy Berger, a former director of the Company, is a principal of WBS Equities, LLC, which is the Manager of Mosaic Real Estate, LLC, which owned the facilities leased by the Company. Additionally, Mosaic Real Estate, LLC is owned in part by Ms. Berger (through the Wendy Berger 1998 Revocable Trust), Benjamin Kovler, the Chairman and Chief Executive Officer of the Company (through KP Capital, LLC), and Anthony Georgiadis, the President and a director of the Company (through Three One Four Holdings, LLC). The terms of these leases range from 7 years to 15 years . For the three and six months ended June 30, 2024, the Company recorded lease expense of $ 166 thousand and $ 305 thousand, respectively, compared to lease expense of $ 137 thousand and $ 276 thousand for the three and six months ended June 30, 2023 , respectively, associated with these leasing arrangements.

Notes Payable

Notes Payable	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Notes Payable	7. NOTES PAYABLE At June 30, 2024 and December 31, 2023, notes payable consisted of the following: June 30, 2024 December 31, 2023 (in thousands) Charitable contributions 1 $ 48 $ 351 Private placement debt dated April 30, 2021 2 224,435 221,680 Mortgage notes 3 85,260 86,492 Total notes payable 309,743 308,523 Less: current portion of notes payable ( 227,265 ) ( 2,996 ) Notes payable, net of current portion $ 82,478 $ 305,527 1 In connection with acquisitions completed in 2017 and 2019, the Company committed to provide charitable contributions of $ 50 thousand per quarter through October 2024 and $ 250 thousand per year through May 2024 , respectively. The net present value of these contributions has been recorded as a liability with interest rates ranging between 2.17 % - 7.00 % . 2 The April 30, 2021 private placement debt, as amended on October 21, 2021 (the “April 30, 2021 Notes”), were issued in an aggregate amount of $ 249,934 thousand with an interest rate of 7 % , maturing on April 30, 2025 . The outstanding principal balance of the April 30, 2021 Notes was $ 224,435 thousand as of June 30, 2024 and December 31, 2023. The April 30, 2021 Notes were recorded net of debt discount which was fully amortized as of June 30, 2024, and had a carrying value of $ 2,755 thousand as of December 31, 2023 . 3 The Company has issued various mortgage notes at an aggregate value of $ 88,785 thousand in connection with various operating properties as of June 30, 2024 and December 31, 2023. The mortgage notes were issued at a discount, the carrying value of which was $ 671 thousand and $ 725 thousand, and are presented net of principal payments of $ 2,854 thousand and $ 1,568 thousand as of June 30, 2024 and December 31, 2023, respectively. These mortgage notes mature between August 20, 2025 and June 5, 2035 with interest rates ranging between 5.00 % and 7.77 % . (a) April 30, 2021 Private Placement Financing: As of June 30, 2024, the Company reclassified the April 30, 2021 Notes to current portion of notes payable on the unaudited interim condensed consolidated balance sheets due to its approaching maturity. The Company is actively evaluating potential partners to refinance the April 30, 2021 Notes. While the exact amount of capital required for the refinancing has not yet been determined, the Company possesses the ability to fully repay the April 30, 2021 Notes if necessary. The Company remains confident in its ability to secure acceptable financing terms or utilize its cash reserves to settle the obligation.

Warrants

Warrants	6 Months Ended
	Jun. 30, 2024
Warrants and Rights Note Disclosure [Abstract]
Warrants	8. WARRANTS As part of the terms of the Company’s issuance of the April 30, 2021 Notes, as well as other financing arrangements, the Company issued warrants, which allow the holders to purchase Subordinate Voting Shares at an exercise price determined at the time of issuance. The following table summarizes the number of warrants outstanding as of June 30, 2024 and December 31, 2023: Liability Classified Equity Classified Number of Shares Weighted Average Exercise Price (C$) Weighted Average Remaining Contractual Life Number of Shares Weighted Average Exercise Price (USD) Weighted Average Balance as of December 31, 2023 1,997,208 C$ 18.03 0.50 1,737,347 $ 31.83 2.38 Warrants Expired ( 1,606,533 ) — — — — — Balance as of June 30, 2024 390,675 C$ 12.42 0.46 1,737,347 $ 31.83 1.88 (a) Liability Classified Warrants Outstanding The following table summarizes the fair value of the liability classified warrants at June 30, 2024 and December 31, 2023: Fair Value Warrant Liability Strike Price Warrants Outstanding June 30, 2024 December 31, 2023 Change (in thousands) Private Placement Financing Warrants Issued May 2019 C$ 19.39 — $ — $ 1,673 $ ( 1,673 ) Modification Warrants Issued November 2019 C$ 12.04 316,947 1,280 1,151 129 Additional Modification Warrants Issued May 2020 C$ 14.03 73,728 303 293 10 Totals 390,675 $ 1,583 $ 3,117 $ ( 1,534 ) During the three and six months ended June 30, 2024 and 2023, the Company recorded gains of $ 3,641 thousand and $ 1,534 thousand, and $ 621 thousand and $ 2,263 thousand, respectively, on the change in the fair value of the warrant liability within other income (expense) on the unaudited interim condensed consolidated statements of operations. The following table summarizes the significant assumptions used in determining the fair value of the warrant liability as of each reporting date (see Note 13 - Fair Value Measurements for additional details): June 30, December 31, Significant Assumptions 2024 2023 Volatility 74.81 %- 79.97 % 61.76 % - 74.31 % Remaining Term 0.36 - 0.89 years 0.39 - 1.39 years Risk Free Rate 4.02 % 3.91 % 8. WARRANTS (Continued) (b) Equity Classified Warrants Outstanding The Company's equity classified warrants were recorded at fair value at each respective date of issuance. Equity classified warrants are not remeasured at fair value on a recurring basis and are carried at their issuance date fair value. The following table summarizes the carrying amounts of the Company's equity classified warrants at June 30, 2024 and December 31, 2023: Issuance Date Fair Value Warrants June 30, December 31, Warrants Included in Contributed Surplus Strike Price Outstanding 2024 2023 (in thousands) Mortgage Warrants Issued June 2020 $ 9.10 35,000 $ 181 $ 181 Private Placement Refinance Warrants Issued April 2021 $ 32.68 1,459,044 22,259 22,259 Private Placement Refinance Warrants Issued October 2021 $ 30.02 243,303 2,616 2,616 Totals 1,737,347 $ 25,056 $ 25,056 The equity warrants were valued as of the date of issuance using a Black Scholes Option Pricing model. The following table summarizes the significant assumptions used in determining the fair value of the warrants as of each respective issuance date: Significant Assumptions Private Placement Refinancing Warrants Private Placement Refinancing Warrants Mortgage Warrants Date of Issuance October 15, 2021 April 30, 2021 June 5, 2020 Volatility 73 % 73 % 80 % Estimated Term 4 years 4 years 5 years Risk Free Rate 1.12 % 0.74 % 0.37 %

Share Capital

Share Capital	6 Months Ended
	Jun. 30, 2024
Stockholders' Equity Note [Abstract]
Share Capital	9. SHARE CAPITAL Common shares, which include the Company’s Subordinate Voting Shares, Multiple Voting Shares and Super Voting Shares are classified as equity. Incremental costs directly attributable to the issuance of common shares are recognized as a deduction from equity. The proceeds from the exercise of stock options or warrants together with amounts previously recorded in reserves over the applicable vesting periods are recorded as share capital. Income tax relating to transaction costs of an equity transaction is accounted for in accordance with Accounting Standards Codification (“ASC”) 740, Income Taxes . (a) Authorized The Company has the following classes of share capital, with each class having no par value: (i) Subordinate Voting Shares The holders of the Subordinate Voting Shares are entitled to receive dividends which may be declared from time to time and are entitled to one vote per share at meetings of the Company’s shareholders. All Subordinate Voting Shares are ranked equally with regard to the Company’s residual assets. The Company is authorized to issue an unlimited number of no par value Subordinate Voting Shares. (ii) Multiple Voting Shares Each Multiple Voting Share is entitled to 100 votes per share at shareholder meetings of the Company and is exchangeable for 100 Subordinate Voting Shares. The Company is authorized to issue an unlimited number of Multiple Voting Shares. (iii) Super Voting Shares Each Super Voting Share is entitled to 1,000 votes per share at shareholder meetings of the Company and is exchangeable for 100 Subordinate Voting Shares or one Multiple Voting Share. The Company is authorized to issue an unlimited number of Super Voting Shares. (b) Issued and Outstanding A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows: Issued and Outstanding Subordinate Multiple Super As at January 1, 2024 209,871,792 38,531 216,690 Distribution of contingent consideration 1,250,000 — — Issuance of shares upon exercise of options 843,387 — — Issuances of shares upon vesting of RSUs 804,440 — — Repurchase of Subordinate Voting Shares ( 2,725,000 ) — — Exchange of shares 1,084,800 ( 848 ) ( 10,000 ) As at June 30, 2024 211,129,419 37,683 206,690 9. SHARE CAPITAL (Continued) (i) Distribution of Contingent Consideration Dharma Pharmaceuticals, LLC In connection with the Company's 2021 acquisition of Dharma Pharmaceuticals, LLC (“Dharma”), the purchase agreement included contingent consideration of up to $ 65,000 thousand in Subordinate Voting Shares of Green Thumb, dependent upon 1) the successful opening of five retail stores in the Virginia area within the first three years following the signing of the agreement (“Retail Stores Milestone”) and 2) the legal sale of adult-use cannabis in a retail store on or before January 1, 2025 (the “Recreational Sales Milestone”). The Retail Stores Milestone was fully achieved prior to expiration and settled in previous periods. On February 9, 2024, the Company and the former owners of Dharma agreed to amend the conditions of the Recreational Sales Milestone (the “Amended Agreement”). Under the Amended Agreement, the former owners waived their right to the Recreational Sales Milestone in exchange for the delivery of 1,250,000 Subordinate Voting Shares. On February 15, 2024, the Company recorded a gain of $ 15,991 thousand, representing the settlement of the Recreational Sales Milestone and distributed the shares to the former owners of Dharma, which had a fair market value of $ 17,259 thousand, which was based on the value of the shares as traded on the Canadian Securities Exchange on the date of distribution. The gain was recorded within sales general and administrative expenses on the unaudited interim condensed consolidated statement of operations. (ii) Repurchase of Subordinate Voting Shares On September 5, 2023, the Company's Board of Directors authorized the repurchase of up to 5 %, or 10,486,951 of its Subordinate Voting Shares over a 12-month period at an aggregate cost of up to $ 50,000 thousand. On February 28, 2024, the Company's Board of Directors authorized an increase in its share repurchase program of $50,000 thousand. During the six months ended June 30, 2024, the Company repurchased 2,725,000 Subordinate Voting Shares at an average price of $ 12.27 per share, bringing the total remaining repurchase ability to approximately $ 26,700 thousand through September 10, 2024. (c) Stock-Based Compensation The Company operates equity settled stock-based remuneration plans for its eligible directors, officers, employees and consultants. All goods and services received in exchange for the grant of any stock-based payments are measured at their fair value unless the fair value cannot be estimated reliably. If the Company cannot estimate reliably the fair value of the goods and services received, the Company measures their value indirectly by reference to the fair value of the equity instruments granted. For transactions with employees and others providing similar services, the Company measures the fair value of the services by reference to the fair value of the equity instruments granted. Equity settled stock-based payments under stock-based payment plans are ultimately recognized as an expense in profit or loss with a corresponding credit to equity. In June 2018, the Company established the Green Thumb Industries Inc. 2018 Stock and Incentive Plan, which was amended by Amendment No. 1 and Amendment No. 2 thereto (as amended, the “Plan”). The maximum number of Restricted Stock Units (“RSUs”) and options outstanding under the Plan at any time shall not exceed 10 % of the then issued and outstanding shares on an as-converted basis. The Company recognizes compensation expense for RSUs and options on a straight-line basis over the requisite service period of the award. Non-market vesting conditions are included in the assumptions about the number of options that are expected to become exercisable. Estimates are subsequently revised if there is any indication that the number of options expected to vest differs from the previous estimate. Any cumulative adjustment prior to vesting is recognized in the current period with no adjustment to prior periods for expense previously recognized. Option and RSU awards generally vest over three years, and options typically have a life of five to ten years. Option grants under the Plan are determined by the Compensation Committee of the Company’s Board of Directors with the option price set at no less than 100% of the fair market value of a share on the date of grant. 9. SHARE CAPITAL (Continued) (c) Stock-Based Compensation (Continued) Stock option activity is summarized as follows: Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Life Balance as of December 31, 2023 10,071,467 $ 11.75 4.31 Granted 797,289 14.96 Exercised ( 843,387 ) 8.81 Forfeited ( 828,488 ) 14.06 Balance as of June 30, 2024 9,196,881 $ 12.44 4.41 Exercisable as of June 30, 2024 4,214,462 $ 8.00 3.78 The Company used the Black-Scholes option pricing model to estimate the fair value of the options granted during the six months ended June 30, 2024 and the year ended December 31, 2023, using the following ranges of assumptions: June 30, December 31, 2024 2023 Risk-free interest rate 3.25 % - 3.92 % 3.06 % - 4.32 % Expected dividend yield 0 % 0 % Expected volatility 62 % - 64 % 64 % Expected option life 4.46 - 4.5 years 3.5 – 4.5 years As permitted under ASC 718, the Company has made an accounting policy choice to account for forfeitures when they occur. The following table summarizes the number of unvested RSU awards as of June 30, 2024 and December 31, 2023 and the changes during the six months ended June 30, 2024: Number of Shares Weighted Average Grant Date Fair Value Unvested Shares at December 31, 2023 3,620,638 $ 9.25 Granted 2,458,964 14.75 Forfeited ( 609,639 ) 11.29 Vested ( 804,440 ) 9.89 Unvested Shares at June 30, 2024 4,665,523 $ 11.88 The stock-based compensation expense for the three and six months ended June 30, 2024 and 2023 was as follows: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (in thousands) (in thousands) Stock options expense $ 2,637 $ 4,303 $ 5,694 $ 8,786 Restricted Stock Units 6,229 3,078 9,662 4,834 Total Stock Based Compensation Expense $ 8,866 $ 7,381 $ 15,356 $ 13,620 As of June 30, 2024, $ 63,591 thousand of total unrecognized expense related to stock-based compensation awards is expected to be recognized over a weighted-average period of 2.21 years.

Income Tax Expense

Income Tax Expense	6 Months Ended
	Jun. 30, 2024
Income Tax Disclosure [Abstract]
Income Tax Expense	10. INCOME TAX EXPENSE The following table summarizes the Company’s income tax expense and effective tax rates for the three and six months ended June 30, 2024 and 2023: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Income before Income Taxes $ 52,817 $ 39,455 $ 116,314 $ 82,496 Income Tax Expense 31,899 25,765 64,048 59,401 Effective Tax Rate 60.4 % 65.3 % 55.1 % 72.0 % The effective tax rates for the three months ended June 30, 2024 and 2023 were based on the Company’s forecasted annualized effective tax rates and were adjusted for discrete items that occurred within the periods presented. Due to its cannabis operations, the Company is subject to the limitations of the U.S. Internal Revenue Code of 1986, as amended (“IRC”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E. Therefore, the effective tax rate can be highly variable and may not necessarily correlate with pre-tax income and provides for effective tax rates that are well in excess of statutory tax rates. Taxes paid during the six months ended June 30, 2024 and 2023 were $ 52,904 thousand and $ 52,134 thousand, respectively.

Other Income (Expense)

Other Income (Expense)	6 Months Ended
	Jun. 30, 2024
Other Income and Expenses [Abstract]
Other Income (Expense)	11. OTHER INCOME (EXPENSE) For the three and six months ended June 30, 2024 and 2023 other income (expense) was comprised of the following: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (in thousands) (in thousands) Fair value adjustments on equity investments $ ( 472 ) $ ( 655 ) $ 167 $ ( 1,134 ) Fair value adjustments on warrants issued 3,641 621 1,534 2,263 Loss from equity method investments ( 772 ) ( 432 ) ( 1,100 ) ( 750 ) Other 67 196 100 275 Total Other Income (Expense) $ 2,464 $ ( 270 ) $ 701 $ 654

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	12. COMMITMENTS AND CONTINGENCIES The Company is subject to lawsuits, investigations and other claims related to employment, commercial and other matters that arise out of operations in the normal course of business. Periodically, the Company reviews the status of each significant matter and assesses the potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable, and the amount can be reliably estimated, such amount is recognized in other liabilities. Contingent liabilities are measured at management’s best estimate of the expenditure required to settle the obligation at the end of the reporting period and are discounted to present value where the effect is material. The Company performs evaluations to identify contingent liabilities for contracts. Contingent consideration is measured upon acquisition and is estimated using probability weighting of potential payouts. Subsequent changes in the estimated contingent consideration from the final purchase price allocation are recognized in the Company’s unaudited interim condensed consolidated statements of operations. (a) Contingencies The Company’s operations are subject to a variety of local and state regulations. Failure to comply with one or more of those regulations could result in fines, sanctions, restrictions on its operations, or losses of permits that could result in the Company ceasing operations in that specific state or local jurisdiction. The Company may be subject to regulatory fines, penalties, or restrictions in the future as cannabis and other regulations continue to evolve and are subject to differing interpretations. (b) Claims and Litigation From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business. Subsequent to June 30, 2024 , the Company received Findings of Fact and Conclusions of Law from an October 30, 2019 complaint filed against Green Thumb (“Defendant”) alleging Defendant breached a commercial property lease with ineffective termination. The court ruled in favor of Plaintiff in the amount of $ 7,307 thousand, representing unpaid rent. In addition, the court found Defendant liable for attorney fees, which have yet to be determined. As of June 30, 2024, the Company accrued the amount of probable loss that can reasonably be estimated within accrued liabilities on the unaudited interim condensed consolidated balance sheets. No final Order of Judgment has been entered in the case and the Company has reserved all rights and intends to contest the findings, including an appeal if necessary. Other than the matter discussed above, as of June 30, 2024 and December 31, 2023 , there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of the Company’s consolidated operations. There are also no proceedings in which any of the Company’s directors, officers or affiliates is an adverse party or has a material interest adverse to the Company’s interest. (c) Construction Commitments As of June 30, 2024, the Company held approximately $ 5,400 thousand of open construction commitments to contractors on work being performed.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2024
Disclosure Text Block Supplement [Abstract]
Fair Value Measurements	13. FAIR VALUE MEASUREMENTS The Company applies fair value accounting for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities that are required to be recorded at fair value, the Company considers all related factors of the asset by market participants in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions, and credit risk. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels, and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities; Level 2 – Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly; and Level 3 – Inputs for the asset or liability that are not based on observable market data. (a) Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, investments, accounts payable and accrued liabilities, notes payable, warrant liability, and contingent consideration payable. It was not practicable to estimate the fair value of the Company's long-term notes payable, which consist of charitable contributions, private placement debt and mortgage notes, since there were no quoted market prices or active trading markets. The carrying amount of notes payable at June 30, 2024 and December 31, 2023 was $ 309,743 thousand and $ 308,523 thousand, respectively, which includes $ 227,265 thousand and $ 2,996 thousand, respectively, of short-term debt due within one year. Financial instruments recorded at fair value are classified using a fair value hierarchy that reflects the significance of the inputs to fair value measurements. The fair values of the Company’s financial instruments associated with each of the three levels of the hierarchy are: As of June 30, 2024 (in thousands) Level 1 Level 2 Level 3 Total Cash and Cash Equivalents $ 196,142 $ — $ — $ 196,142 Investments 24,695 — 36,717 61,412 Warrant Liability — — ( 1,583 ) ( 1,583 ) $ 220,837 $ — $ 35,134 $ 255,971 As of December 31, 2023 (in thousands) Level 1 Level 2 Level 3 Total Cash and Cash Equivalents $ 161,634 $ — $ — $ 161,634 Investments 24,215 — 40,146 64,361 Contingent Consideration Payable — — ( 33,250 ) ( 33,250 ) Warrant Liability — — ( 3,117 ) ( 3,117 ) $ 185,849 $ — $ 3,779 $ 189,628

Segment Reporting

Segment Reporting	6 Months Ended
	Jun. 30, 2024
Segment Reporting [Abstract]
Segment Reporting	14. SEGMENT REPORTING The Company operates in two segments: the cultivation, production and sale of cannabis products to retail stores (“Consumer Packaged Goods”) and retailing of cannabis to patients and consumers (“Retail”). The Company does not allocate operating expenses to these business units, nor does it allocate specific assets. Additionally, the CODM does not review total assets or net income (loss) by segments; therefore, such information is not presented below. The below table presents revenues by type for the three and six months ended June 30, 2024 and 2023: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (in thousands) (in thousands) Revenues, Net of Discounts Retail $ 204,656 $ 188,044 $ 408,434 $ 376,922 Consumer Packaged Goods 156,323 136,054 306,235 261,671 Intersegment Eliminations ( 80,832 ) ( 71,710 ) ( 158,716 ) ( 137,669 ) Total Revenues, Net of Discounts $ 280,147 $ 252,388 $ 555,953 $ 500,924 Depreciation and Amortization Retail $ 10,436 $ 9,109 $ 20,683 $ 17,941 Consumer Packaged Goods 17,549 15,125 35,077 29,794 Intersegment Eliminations — — — — Total Depreciation and Amortization $ 27,985 $ 24,234 $ 55,760 $ 47,735 Income Taxes Retail $ 16,405 $ 13,328 $ 33,969 $ 32,339 Consumer Packaged Goods 15,494 12,437 30,079 27,062 Intersegment Eliminations — — — — Total Income Taxes $ 31,899 $ 25,765 $ 64,048 $ 59,401 Goodwill assigned to the Retail segment as of June 30, 2024 and December 31, 2023 was $ 273,802 thousand, respectively. Intangible assets, net assigned to the Retail segment as of June 30, 2024 and December 31, 2023 was $ 266,423 thousand and $ 278,492 thousand, respectively. Goodwill assigned to the Consumer Packaged Goods segment as of June 30, 2024 and December 31, 2023 was $ 315,889 thousand, respectively. Intangible assets, net assigned to the Consumer Packaged Goods segment as of June 30, 2024 and December 31, 2023 was $ 247,011 thousand and $ 260,186 thousand, respectively. The Company’s assets are aggregated into two reportable segments (Retail and Consumer Packaged Goods). For the purposes of testing goodwill, Green Thumb has identified two reporting units which align with our reportable segments (Retail and Consumer Packaged Goods). All revenues are derived from customers domiciled in the United States and all assets are located in the United States.

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited interim condensed consolidated financial statements include the accounts of Green Thumb and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the rules and regulations of the U.S. Securities & Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and, accordingly, certain information, footnotes and disclosures normally included in the annual financial statements, prepared in accordance with GAAP, have been condensed or omitted in accordance with SEC rules and regulations. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”). In the opinion of management, the financial data presented includes all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented. Certain previously reported amounts have been reclassified between line items to conform to the current period presentation. Results of interim periods should not be considered indicative of the results for the full year. These unaudited interim condensed consolidated financial statements include estimates and assumptions of management that affect the amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from these estimates.
Significant Accounting Policies	Significant Accounting Policies There have been no changes to the Company’s significant accounting policies as described in Note 2 to the Company's Consolidated Financial Statements included in the 2023 Form 10-K.
Earnings per Share	Earnings per Share Basic earnings per share is calculated using the treasury stock method, by dividing the net earnings attributable to shareholders by the weighted average number of common shares outstanding during each of the periods presented. Contingently issuable shares (including shares held in escrow) are not considered outstanding common shares and consequently are not included in the earnings per share calculation. Diluted earnings per share is calculated using the treasury stock method by adjusting the weighted average number of common shares outstanding to assume conversion of all dilutive potential common shares. The Company has three categories of potentially dilutive common share equivalents: restricted stock units, stock options and warrants. As of June 30, 2024, the Company had 9,196,881 options, 4,665,523 restricted stock units and 2,128,022 warrants outstanding. As of June 30, 2023, the Company had 10,874,051 options, 3,453,460 restricted stock units and 3,734,555 warrants outstanding. Earnings per Share ( Continued ) In order to determine diluted earnings per share, it is assumed that any proceeds from the vesting of dilutive unvested restricted stock units, or exercise of unvested stock options and warrants would be used to repurchase common shares at the average market price during the period. Under the treasury stock method, the diluted earnings per share calculation excludes any potential conversion of stock options and convertible debt that would increase earnings per share or decrease loss per share. For the three months ended June 30, 2024, the computation of diluted earnings per share included 1,632,323 options, 971,792 restricted stock units, and 117,434 warrants. For the six months ended June 30, 2024, the computation of diluted earnings per share included 1,625,478 options, 1,939,848 restricted stock units, and 119,259 warrants. For the three months ended June 30, 2023, the computation of diluted earnings per share included 135,894 options and 287,259 restricted stock units. For the six months ended June 30, 2023, the computation of diluted earnings per share included 167,191 options and 1,587,917 restricted stock units. There were no dilutive warrants during the three and six months ended June 30, 2023 as the strike price was greater than the average stock price for the period. For the three and six months ended June 30, 2024, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 896,810 and 978,895 , respectively. For the three and six months ended June 30, 2023 , the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 3,399,518 and 3,473,866 , respectively.
Recently Issued Accounting Standards	Recently Issued Accounting Standards (i) In November 2023, the FASB issued Accounting Standards Update ( “ ASU”) No. 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures , to provide enhanced segment disclosures. The standard will require disclosures about significant segment expense categories and amounts for each reportable segment, for all periods presented. Additionally, the standard requires public entities to disclose the title and position of the Chief Operating Decision Maker ( “ CODM”) in the consolidated financial statements. These enhanced disclosures are required for all entities on an interim and annual basis, effective for fiscal years beginning after December 15, 2023, and interim periods within annual periods beginning after December 15, 2024. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements. (ii) In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , which is intended to provide enhancements to annual income tax disclosures. The standard will require more detailed information in the rate reconciliation table and for income taxes paid, among other enhancements. The standard is effective for years beginning after December 15, 2024 and early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements. The Company reviews recently issued accounting standards on a quarterly basis and has determined there are no standards yet to be adopted which are relevant to the business for disclosure.

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Jun. 30, 2024
Inventory Disclosure [Abstract]
Summary of inventory	The Company’s inventories include the following at June 30, 2024 and December 31, 2023: June 30, 2024 December 31, 2023 (in thousands) Raw Material $ 2,205 $ 1,547 Packaging and Miscellaneous 11,021 10,661 Work in Process 51,219 47,029 Finished Goods 70,320 57,631 Reserve for Obsolete Inventory ( 4,235 ) ( 3,898 ) Total Inventories, Net $ 130,530 $ 112,970

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Jun. 30, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	At June 30, 2024 and December 31, 2023, property and equipment consisted of the following: June 30, 2024 December 31, 2023 (in thousands) Buildings and Improvements $ 354,195 $ 353,912 Equipment, Computers and Furniture 182,041 171,522 Leasehold Improvements 222,073 200,232 Land Improvements 1,168 1,046 Capitalized Interest 31,603 30,817 Total Property and Equipment 791,080 757,529 Less: Accumulated Depreciation ( 157,168 ) ( 127,290 ) Property and Equipment, net 633,912 630,239 Land 33,725 33,725 Assets Under Construction 26,402 23,142 Property and Equipment, net $ 694,039 $ 687,106

Intangible Assets And Goodwill

Intangible Assets And Goodwill (Tables)	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of intangible assets	At June 30, 2024 and December 31, 2023, intangible assets consisted of the following: June 30, 2024 December 31, 2023 Gross Carrying Amount Accumulated Amortization Net Book Value Gross Carrying Amount Accumulated Amortization Net Book Value (in thousands) (in thousands) Licenses and Permits $ 660,716 $ 179,813 $ 480,903 $ 660,716 $ 157,764 $ 502,952 Trademarks 41,511 14,746 26,765 41,511 13,378 28,133 Customer Relationships 24,438 18,672 5,766 24,438 16,927 7,511 Non-Competition Agreements 2,565 2,565 — 2,565 2,483 82 Total Intangible Assets $ 729,230 $ 215,796 $ 513,434 $ 729,230 $ 190,552 $ 538,678
Summary of estimated annual amortization expense related to intangible assets	The following table outlines the estimated annual amortization expense related to intangible assets as of June 30, 2024: Estimated Year Ending December 31, (in thousands) Remainder of 2024 $ 25,148 2025 50,294 2026 47,332 2027 46,803 2028 46,803 2029 and Thereafter 297,054 $ 513,434
Summary of Goodwill And Intangible Assets Disclosure	At June 30, 2024 and December 31, 2023 the balances of goodwill, by segment, consisted of the following: June 30, 2024 December 31, 2023 (in thousands) Retail $ 273,802 $ 273,802 Consumer Packaged Goods 315,889 315,889 Total $ 589,691 $ 589,691

Investments (Tables)

Investments (Tables)	6 Months Ended
	Jun. 30, 2024
Investments [Abstract]
Schedule Of Long Term Investments	The following table summarizes the changes in the Company’s investments during the six months ended June 30, 2024 and year ended December 31, 2023: June 30, 2024 December 31, 2023 (in thousands) Beginning $ 64,361 $ 74,169 Additions 2,965 8,200 Disposals ( 6,248 ) ( 498 ) Fair value adjustment 334 ( 17,460 ) Transfers and other — ( 50 ) Ending $ 61,412 $ 64,361
Schedule of Change in Fair Value of Company's Investments	The following table summarizes the change in fair value associated with the Company's equity investments and notes receivable instruments recorded during the three and six months ended June 30, 2024 and 2023. Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (in thousands) Equity Investments $ ( 481 ) $ ( 655 ) $ 158 $ ( 1,134 ) Notes Receivable Instruments 9 — 9 — Accrued Interest on Notes Receivable Instruments 84 78 167 206 Net fair value gains (losses) $ ( 388 ) $ ( 577 ) $ 334 $ ( 928 )

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2024
Leases [Abstract]
Schedule Of Other Information Related To Operating Leases	Other information related to operating leases as of June 30, 2024 and December 31, 2023 were as follows: June 30, 2024 December 31, 2023 Weighted average remaining lease term (years) 11.19 11.75 Weighted average discount rate 12.29 % 12.40 %
Lessee, Operating Lease, Liability, Maturity	Maturities of lease liabilities for operating leases as of June 30, 2024 were as follows: Maturities of Lease Liability Year Ending December 31, Third-Party Related Party Total (in thousands) Remainder of 2024 $ 22,626 $ 292 $ 22,918 2025 44,893 592 45,485 2026 45,102 603 45,705 2027 45,622 572 46,194 2028 44,898 364 45,262 2029 and Thereafter 329,894 1,364 331,258 Total Lease Payments 533,035 3,787 536,822 Less: Interest ( 261,707 ) ( 1,231 ) ( 262,938 ) Present Value of Lease Liability $ 271,328 $ 2,556 $ 273,884

Notes Payable (Tables)

Notes Payable (Tables)	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Schedule of Debt	At June 30, 2024 and December 31, 2023, notes payable consisted of the following: June 30, 2024 December 31, 2023 (in thousands) Charitable contributions 1 $ 48 $ 351 Private placement debt dated April 30, 2021 2 224,435 221,680 Mortgage notes 3 85,260 86,492 Total notes payable 309,743 308,523 Less: current portion of notes payable ( 227,265 ) ( 2,996 ) Notes payable, net of current portion $ 82,478 $ 305,527 1 In connection with acquisitions completed in 2017 and 2019, the Company committed to provide charitable contributions of $ 50 thousand per quarter through October 2024 and $ 250 thousand per year through May 2024 , respectively. The net present value of these contributions has been recorded as a liability with interest rates ranging between 2.17 % - 7.00 % . 2 The April 30, 2021 private placement debt, as amended on October 21, 2021 (the “April 30, 2021 Notes”), were issued in an aggregate amount of $ 249,934 thousand with an interest rate of 7 % , maturing on April 30, 2025 . The outstanding principal balance of the April 30, 2021 Notes was $ 224,435 thousand as of June 30, 2024 and December 31, 2023. The April 30, 2021 Notes were recorded net of debt discount which was fully amortized as of June 30, 2024, and had a carrying value of $ 2,755 thousand as of December 31, 2023 . 3 The Company has issued various mortgage notes at an aggregate value of $ 88,785 thousand in connection with various operating properties as of June 30, 2024 and December 31, 2023. The mortgage notes were issued at a discount, the carrying value of which was $ 671 thousand and $ 725 thousand, and are presented net of principal payments of $ 2,854 thousand and $ 1,568 thousand as of June 30, 2024 and December 31, 2023, respectively. These mortgage notes mature between August 20, 2025 and June 5, 2035 with interest rates ranging between 5.00 % and 7.77 % .

Warrants (Tables)

Warrants (Tables)	3 Months Ended	6 Months Ended
	Mar. 31, 2024	Jun. 30, 2024
Class of Warrant or Right [Line Items]
Schedule of Stockholders' Equity Note, Warrants or Rights		The following table summarizes the number of warrants outstanding as of June 30, 2024 and December 31, 2023: Liability Classified Equity Classified Number of Shares Weighted Average Exercise Price (C$) Weighted Average Remaining Contractual Life Number of Shares Weighted Average Exercise Price (USD) Weighted Average Balance as of December 31, 2023 1,997,208 C$ 18.03 0.50 1,737,347 $ 31.83 2.38 Warrants Expired ( 1,606,533 ) — — — — — Balance as of June 30, 2024 390,675 C$ 12.42 0.46 1,737,347 $ 31.83 1.88
Liability Classified Warrant [member]
Class of Warrant or Right [Line Items]
Schedule Of Fair Value Of Warrant Liability		The following table summarizes the fair value of the liability classified warrants at June 30, 2024 and December 31, 2023: Fair Value Warrant Liability Strike Price Warrants Outstanding June 30, 2024 December 31, 2023 Change (in thousands) Private Placement Financing Warrants Issued May 2019 C$ 19.39 — $ — $ 1,673 $ ( 1,673 ) Modification Warrants Issued November 2019 C$ 12.04 316,947 1,280 1,151 129 Additional Modification Warrants Issued May 2020 C$ 14.03 73,728 303 293 10 Totals 390,675 $ 1,583 $ 3,117 $ ( 1,534 )
Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability		The following table summarizes the significant assumptions used in determining the fair value of the warrant liability as of each reporting date (see Note 13 - Fair Value Measurements for additional details): June 30, December 31, Significant Assumptions 2024 2023 Volatility 74.81 %- 79.97 % 61.76 % - 74.31 % Remaining Term 0.36 - 0.89 years 0.39 - 1.39 years Risk Free Rate 4.02 % 3.91 %
Equity Classified Warrant [member]
Class of Warrant or Right [Line Items]
Schedule of Stockholders' Equity Note, Warrants or Rights	The following table summarizes the carrying amounts of the Company's equity classified warrants at June 30, 2024 and December 31, 2023: Issuance Date Fair Value Warrants June 30, December 31, Warrants Included in Contributed Surplus Strike Price Outstanding 2024 2023 (in thousands) Mortgage Warrants Issued June 2020 $ 9.10 35,000 $ 181 $ 181 Private Placement Refinance Warrants Issued April 2021 $ 32.68 1,459,044 22,259 22,259 Private Placement Refinance Warrants Issued October 2021 $ 30.02 243,303 2,616 2,616 Totals 1,737,347 $ 25,056 $ 25,056
Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability		The equity warrants were valued as of the date of issuance using a Black Scholes Option Pricing model. The following table summarizes the significant assumptions used in determining the fair value of the warrants as of each respective issuance date: Significant Assumptions Private Placement Refinancing Warrants Private Placement Refinancing Warrants Mortgage Warrants Date of Issuance October 15, 2021 April 30, 2021 June 5, 2020 Volatility 73 % 73 % 80 % Estimated Term 4 years 4 years 5 years Risk Free Rate 1.12 % 0.74 % 0.37 %

Share Capital (Tables)

Share Capital (Tables)	6 Months Ended
	Jun. 30, 2024
Disclosure of Share Capital [Line Items]
Schedule of Common Stock Outstanding Roll Forward	A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows: Issued and Outstanding Subordinate Multiple Super As at January 1, 2024 209,871,792 38,531 216,690 Distribution of contingent consideration 1,250,000 — — Issuance of shares upon exercise of options 843,387 — — Issuances of shares upon vesting of RSUs 804,440 — — Repurchase of Subordinate Voting Shares ( 2,725,000 ) — — Exchange of shares 1,084,800 ( 848 ) ( 10,000 ) As at June 30, 2024 211,129,419 37,683 206,690
Share-based Payment Arrangement, Option, Activity	Stock option activity is summarized as follows: Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Life Balance as of December 31, 2023 10,071,467 $ 11.75 4.31 Granted 797,289 14.96 Exercised ( 843,387 ) 8.81 Forfeited ( 828,488 ) 14.06 Balance as of June 30, 2024 9,196,881 $ 12.44 4.41 Exercisable as of June 30, 2024 4,214,462 $ 8.00 3.78
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The Company used the Black-Scholes option pricing model to estimate the fair value of the options granted during the six months ended June 30, 2024 and the year ended December 31, 2023, using the following ranges of assumptions: June 30, December 31, 2024 2023 Risk-free interest rate 3.25 % - 3.92 % 3.06 % - 4.32 % Expected dividend yield 0 % 0 % Expected volatility 62 % - 64 % 64 % Expected option life 4.46 - 4.5 years 3.5 – 4.5 years
Schedule of Stock-Based Compensation Expense	The stock-based compensation expense for the three and six months ended June 30, 2024 and 2023 was as follows: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (in thousands) (in thousands) Stock options expense $ 2,637 $ 4,303 $ 5,694 $ 8,786 Restricted Stock Units 6,229 3,078 9,662 4,834 Total Stock Based Compensation Expense $ 8,866 $ 7,381 $ 15,356 $ 13,620
Restricted Stock Units
Disclosure of Share Capital [Line Items]
Non-vested Restricted Stock Shares Activity	The following table summarizes the number of unvested RSU awards as of June 30, 2024 and December 31, 2023 and the changes during the six months ended June 30, 2024: Number of Shares Weighted Average Grant Date Fair Value Unvested Shares at December 31, 2023 3,620,638 $ 9.25 Granted 2,458,964 14.75 Forfeited ( 609,639 ) 11.29 Vested ( 804,440 ) 9.89 Unvested Shares at June 30, 2024 4,665,523 $ 11.88

Income Tax Expense (Tables)

Income Tax Expense (Tables)	6 Months Ended
	Jun. 30, 2024
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit)	The following table summarizes the Company’s income tax expense and effective tax rates for the three and six months ended June 30, 2024 and 2023: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Income before Income Taxes $ 52,817 $ 39,455 $ 116,314 $ 82,496 Income Tax Expense 31,899 25,765 64,048 59,401 Effective Tax Rate 60.4 % 65.3 % 55.1 % 72.0 %

Other Income (Expense) (Tables)

Other Income (Expense) (Tables)	6 Months Ended
	Jun. 30, 2024
Other Income and Expenses [Abstract]
Schedule of Other Nonoperating Income (Expense)	For the three and six months ended June 30, 2024 and 2023 other income (expense) was comprised of the following: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (in thousands) (in thousands) Fair value adjustments on equity investments $ ( 472 ) $ ( 655 ) $ 167 $ ( 1,134 ) Fair value adjustments on warrants issued 3,641 621 1,534 2,263 Loss from equity method investments ( 772 ) ( 432 ) ( 1,100 ) ( 750 ) Other 67 196 100 275 Total Other Income (Expense) $ 2,464 $ ( 270 ) $ 701 $ 654

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2024
Disclosure Text Block Supplement [Abstract]
Fair Value Measurements, Recurring and Nonrecurring	The fair values of the Company’s financial instruments associated with each of the three levels of the hierarchy are: As of June 30, 2024 (in thousands) Level 1 Level 2 Level 3 Total Cash and Cash Equivalents $ 196,142 $ — $ — $ 196,142 Investments 24,695 — 36,717 61,412 Warrant Liability — — ( 1,583 ) ( 1,583 ) $ 220,837 $ — $ 35,134 $ 255,971 As of December 31, 2023 (in thousands) Level 1 Level 2 Level 3 Total Cash and Cash Equivalents $ 161,634 $ — $ — $ 161,634 Investments 24,215 — 40,146 64,361 Contingent Consideration Payable — — ( 33,250 ) ( 33,250 ) Warrant Liability — — ( 3,117 ) ( 3,117 ) $ 185,849 $ — $ 3,779 $ 189,628

Segment Reporting (Tables)

Segment Reporting (Tables)	6 Months Ended
	Jun. 30, 2024
Segment Reporting [Abstract]
Schedule of Revenues	The below table presents revenues by type for the three and six months ended June 30, 2024 and 2023: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (in thousands) (in thousands) Revenues, Net of Discounts Retail $ 204,656 $ 188,044 $ 408,434 $ 376,922 Consumer Packaged Goods 156,323 136,054 306,235 261,671 Intersegment Eliminations ( 80,832 ) ( 71,710 ) ( 158,716 ) ( 137,669 ) Total Revenues, Net of Discounts $ 280,147 $ 252,388 $ 555,953 $ 500,924 Depreciation and Amortization Retail $ 10,436 $ 9,109 $ 20,683 $ 17,941 Consumer Packaged Goods 17,549 15,125 35,077 29,794 Intersegment Eliminations — — — — Total Depreciation and Amortization $ 27,985 $ 24,234 $ 55,760 $ 47,735 Income Taxes Retail $ 16,405 $ 13,328 $ 33,969 $ 32,339 Consumer Packaged Goods 15,494 12,437 30,079 27,062 Intersegment Eliminations — — — — Total Income Taxes $ 31,899 $ 25,765 $ 64,048 $ 59,401

Overview and Basis of Present_2

Overview and Basis of Presentation - Additional Information (Detail) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Number of Shares Outstanding, Diluted	240,137,922	238,423,288	240,768,497	239,455,964
Anti-dilutive stock options excluded from the computation of diluted earnings per share	896,810	3,399,518	978,895	3,473,866
Employee Stock Option
Number of Shares Outstanding, Diluted			9,196,881	10,874,051
Weighted Average Number Diluted Shares Outstanding Adjustment	1,632,323	135,894	1,625,478	167,191
Restricted Stock Units
Number of Shares Outstanding, Diluted			4,665,523	3,453,460
Weighted Average Number Diluted Shares Outstanding Adjustment	971,792	287,259	1,939,848	1,587,917
Warrant
Number of Shares Outstanding, Diluted			2,128,022	3,734,555
Weighted Average Number Diluted Shares Outstanding Adjustment	117,434		119,259

Inventories - Summary of invent

Inventories - Summary of inventory (Detail) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Inventory [Line Items]
Raw Material	$ 2,205	$ 1,547
Packaging and Miscellaneous	11,021	10,661
Work in Process	51,219	47,029
Finished Goods	70,320	57,631
Reserve for Obsolete Inventory	(4,235)	(3,898)
Total Inventories, net	$ 130,530	$ 112,970

Property and Equipment - Proper

Property and Equipment - Property, Plant and Equipment (Detail) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Total Property and Equipment	$ 791,080	$ 757,529
Less: Accumulated Depreciation	(157,168)	(127,290)
Property and Equipment, net	633,912	630,239
Property and Equipment, net	694,039	687,106
Land [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	33,725	33,725
Land Improvements [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	1,168	1,046
Assets Under Construction [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	26,402	23,142
Buildings and Improvements [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	354,195	353,912
Equipment, Computers and Furniture [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	182,041	171,522
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	222,073	200,232
Capitalized Interest [Member]
Property, Plant and Equipment [Line Items]
Total Property and Equipment	$ 31,603	$ 30,817

Property and Equipment - Additi

Property and Equipment - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disclosure of Property of Equipment [Line Items]
Depreciation expense	$ 15,412	$ 11,490	$ 30,516	$ 22,381
Cost of Sales [Member]
Disclosure of Property of Equipment [Line Items]
Depreciation expense	$ 9,930	$ 7,694	$ 19,723	$ 15,050

Intangible Assets And Goodwil_2

Intangible Assets And Goodwill - Summary Of Intangible Assets (Detail) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 729,230	$ 729,230
Accumulated Amortization	215,796	190,552
Finite-Lived Intangible Assets, Net	513,434	538,678
Licenses And Permits [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	660,716	660,716
Accumulated Amortization	179,813	157,764
Finite-Lived Intangible Assets, Net	480,903	502,952
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	41,511	41,511
Accumulated Amortization	14,746	13,378
Finite-Lived Intangible Assets, Net	26,765	28,133
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	24,438	24,438
Accumulated Amortization	18,672	16,927
Finite-Lived Intangible Assets, Net	5,766	7,511
Non Competition Agreement [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	2,565	2,565
Accumulated Amortization	2,565	2,483
Finite-Lived Intangible Assets, Net	$ 0	$ 82

Intangible Assets And Goodwil_3

Intangible Assets And Goodwill - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Amortization	$ 12,573	$ 12,744	$ 25,244	$ 25,354
Weighted average amortization period			10 years 10 months 28 days
Goodwill net of accumulated impairment losses	57,372		$ 57,372		$ 57,372
Goodwill impairment charge	0	$ 0	0	$ 0
Intangible assets [Member]
Goodwill net of accumulated impairment losses	$ 31,131		$ 31,131		$ 31,131

Intangible Assets And Goodwil_4

Intangible Assets And Goodwill - Summary Of Estimated Annual Amortization Expense Related To Intangible Assets (Detail) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Finite Lived Intangible Assets Future Amortization Expense [Line Items]
Remainder of 2024	$ 25,148
2025	50,294
2026	47,332
2027	46,803
2028	46,803
2029 and Thereafter	297,054
Finite-Lived Intangible Assets, Net	$ 513,434	$ 538,678

Intangible Assets And Goodwil_5

Intangible Assets And Goodwill - Summary Of Goodwill And Intangible Assets Disclosure (Detail) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Goodwill [Line Items]
Goodwill	$ 589,691	$ 589,691
Retail Segment [Member]
Goodwill [Line Items]
Goodwill	273,802	273,802
Consumer Packaged Goods Segment [Member]
Goodwill [Line Items]
Goodwill	$ 315,889	$ 315,889

Investments - Schedule Of Long

Investments - Schedule Of Long Term Investments (Detail) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Longterm Investments [Line Items]
Beginning balance	$ 64,361	$ 74,169
Additions	2,965	8,200
Disposals	(6,248)	(498)
Fair value adjustments	334	(17,460)
Transfers and other	0	(50)
Ending balance	$ 61,412	$ 64,361

Investments - Schedule of Chang

Investments - Schedule of Change in Fair Value of Company's Investments (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Investments [Line Items]
Accrued Interest on Notes Receivable Instruments	$ 84	$ 78	$ 167	$ 206
Fair value (losses) gains	(388)	(577)	334	(928)
Equity Investments
Investments [Line Items]
Fair value (losses) gains	(481)	(655)	158	(1,134)
Notes
Investments [Line Items]
Fair value (losses) gains	$ 9	$ 0	$ 9	$ 0

Investments - Additional Inform

Investments - Additional Information (Detail) - USD ($) $ in Thousands			3 Months Ended		6 Months Ended
	Jan. 09, 2024	Apr. 30, 2021	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2019	Dec. 31, 2017
Investments [Line Items]
Unrealized gains and (losses) recognized on equity investments held			$ (253)	$ (653)	$ 319	$ 1,996
Fair value adjustments			9		9
Investment in non convertible instrument			24,188		24,188		$ 22,214
Debt instrument interest rate								7%	2.17%
Debt Maturity Date		Apr. 30, 2025
Accrued Interest on Notes Receivable Instruments			84	78	167	206
Cannabis Companies [Member]
Investments [Line Items]
Equity interest, fair value disclosure			61,412		61,412		64,361
Fair Value, Inputs, Level 1 [Member]
Investments [Line Items]
Equity interest, fair value disclosure			507		507		2,001
Proceeds from sale of equity interest in privately held entity					1,652	31
Fair value of losses on equity method of investment			(481)	655	158	1,134
Fair value adjustments on equity method investments				0		0
Fair Value, Inputs, Level 3 [Member]
Investments [Line Items]
Equity interest, fair value disclosure			$ 25,953		$ 25,953		25,953
Notes Receivable [Member]
Investments [Line Items]
Accrued Interest on Notes Receivable Instruments	$ 605
Principal amount	$ 4,000
Notes Receivable [Member] | Fair Value, Inputs, Level 1 [Member]
Investments [Line Items]
Debt instrument interest rate			13%		13%
Debt Maturity Date					Apr. 29, 2025
Notes Receivable [Member] | Fair Value, Inputs, Level 3 [Member]
Investments [Line Items]
Investment in non convertible instrument			$ 10,764		$ 10,764		$ 14,193
Accrued Interest on Notes Receivable Instruments			$ 84	$ 78	$ 167	$ 206
Minimum [Member] | Notes Receivable [Member] | Fair Value, Inputs, Level 3 [Member]
Investments [Line Items]
Debt instrument, Term					12 months
Maximum [Member] | Notes Receivable [Member] | Fair Value, Inputs, Level 3 [Member]
Investments [Line Items]
Debt instrument interest rate			10%		10%
Debt instrument, Term					5 years

Leases - Additional Information

Leases - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Acquired Finite-Lived Intangible Assets [Line Items]
Operating lease expense	$ 12,425	$ 12,146	$ 24,676	$ 24,368
Florida And Lllinois [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Operating lease expense	$ 166	$ 137	$ 305	$ 276
Maximum [Member] | Florida And Lllinois [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Lease term	15 years		15 years
Minimum [Member] | Florida And Lllinois [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Lease term	7 years		7 years

Leases - Schedule Of Other Info

Leases - Schedule Of Other Information Related To Operating Leases (Detail)	Jun. 30, 2024	Dec. 31, 2023
Lessee, Lease, Description [Line Items]
Weighted average remaining lease term (years)	11 years 2 months 8 days	11 years 9 months
Weighted average discount rate	12.29%	12.40%

Leases - Lessee Operating Lease

Leases - Lessee Operating Lease Liability Maturity (Detail) $ in Thousands	Jun. 30, 2024 USD ($)
Lessee, Lease, Description [Line Items]
Remainder of 2024	$ 22,918
2025	45,485
2026	45,705
2027	46,194
2028	45,262
2029 and Thereafter	331,258
Total Lease Payments	536,822
Less: Interest	(262,938)
Present Value of Lease Liability	273,884
Third Party [Member]
Lessee, Lease, Description [Line Items]
Remainder of 2024	22,626
2025	44,893
2026	45,102
2027	45,622
2028	44,898
2029 and Thereafter	329,894
Total Lease Payments	533,035
Less: Interest	(261,707)
Present Value of Lease Liability	271,328
Related Party [Member]
Lessee, Lease, Description [Line Items]
Remainder of 2024	292
2025	592
2026	603
2027	572
2028	364
2029 and Thereafter	1,364
Total Lease Payments	3,787
Less: Interest	(1,231)
Present Value of Lease Liability	$ 2,556

Notes Payable - Schedule of Deb

Notes Payable - Schedule of Debt (Detail) - USD ($) $ in Thousands		Jun. 30, 2024		Dec. 31, 2023		Apr. 30, 2021
Debt Instrument [Line Items]
Total notes payable		$ 309,743		$ 308,523
Less: current portion of notes payable		(227,265)		(2,996)
Notes payable, net of current portion		82,478		305,527
Acquired Debt [member]
Debt Instrument [Line Items]
Total notes payable	[1]	48		351
Private Placement Debt April 30, 2021 [Member]
Debt Instrument [Line Items]
Total notes payable		224,435	[2]	221,680	[2]	$ 224,435
Mortgage Notes [Member]
Debt Instrument [Line Items]
Total notes payable	[3]	$ 85,260		$ 86,492
[1] In connection with acquisitions completed in 2017 and 2019, the Company committed to provide charitable contributions of $ 50 thousand per quarter through October 2024 and $ 250 thousand per year through May 2024 , respectively. The net present value of these contributions has been recorded as a liability with interest rates ranging between 2.17 % - 7.00 % The April 30, 2021 private placement debt, as amended on October 21, 2021 (the “April 30, 2021 Notes”), were issued in an aggregate amount of $ 249,934 thousand with an interest rate of 7 % , maturing on April 30, 2025 . The outstanding principal balance of the April 30, 2021 Notes was $ 224,435 thousand as of June 30, 2024 and December 31, 2023. The April 30, 2021 Notes were recorded net of debt discount which was fully amortized as of June 30, 2024, and had a carrying value of $ 2,755 thousand as of December 31, 2023 . The Company has issued various mortgage notes at an aggregate value of $ 88,785 thousand in connection with various operating properties as of June 30, 2024 and December 31, 2023. The mortgage notes were issued at a discount, the carrying value of which was $ 671 thousand and $ 725 thousand, and are presented net of principal payments of $ 2,854 thousand and $ 1,568 thousand as of June 30, 2024 and December 31, 2023, respectively. These mortgage notes mature between August 20, 2025 and June 5, 2035 with interest rates ranging between 5.00 % and 7.77 % .

Notes Payable - Schedule of D_2

Notes Payable - Schedule of Debt (Parenthetical) (Detail) - USD ($) $ in Thousands			6 Months Ended		12 Months Ended
		Apr. 30, 2021	Jun. 30, 2024		Dec. 31, 2023		Dec. 31, 2019	Dec. 31, 2017
Debt Instrument [Line Items]
Charitable Contribution Quarterly Payment							$ 250	$ 50
Charitable Contribution, Date Of Last Payment							May 2024	October 2024
Debt Instrument Interest Rate							7%	2.17%
Notes payable			$ 309,743		$ 308,523
Debt Maturity Date		Apr. 30, 2025
Private Placement Debt April 30, 2021 [Member]
Debt Instrument [Line Items]
Debt Instrument Interest Rate		7%
Notes payable		$ 224,435	224,435	[1]	221,680	[1]
Debt face value		$ 249,934
Debt Instrument Carrying Amount					2,755
Mortgage Notes [Member]
Debt Instrument [Line Items]
Notes payable	[2]		85,260		86,492
Debt face value			88,785		88,785
Debt Instrument Carrying Amount			671		725
Debt Instrument, Annual Principal Payment			$ 2,854		$ 1,568
Mortgage Notes [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt Instrument Interest Rate					7.77%
Debt Maturity Date					Jun. 05, 2035
Mortgage Notes [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt Instrument Interest Rate			5%
Debt Maturity Date			Aug. 20, 2025
[1] The April 30, 2021 private placement debt, as amended on October 21, 2021 (the “April 30, 2021 Notes”), were issued in an aggregate amount of $ 249,934 thousand with an interest rate of 7 % , maturing on April 30, 2025 . The outstanding principal balance of the April 30, 2021 Notes was $ 224,435 thousand as of June 30, 2024 and December 31, 2023. The April 30, 2021 Notes were recorded net of debt discount which was fully amortized as of June 30, 2024, and had a carrying value of $ 2,755 thousand as of December 31, 2023 . The Company has issued various mortgage notes at an aggregate value of $ 88,785 thousand in connection with various operating properties as of June 30, 2024 and December 31, 2023. The mortgage notes were issued at a discount, the carrying value of which was $ 671 thousand and $ 725 thousand, and are presented net of principal payments of $ 2,854 thousand and $ 1,568 thousand as of June 30, 2024 and December 31, 2023, respectively. These mortgage notes mature between August 20, 2025 and June 5, 2035 with interest rates ranging between 5.00 % and 7.77 % .

Warrants - Schedule of Stockhol

Warrants - Schedule of Stockholders' Equity Note, Warrants or Rights (Detail)	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Liability Classified Warrant [member]
Class of Warrant or Right [Line Items]
Number of Shares, Beginning Balance | shares	1,997,208
Number of Shares, Expired | shares	(1,606,533)
Number of Shares, Ending Balance | shares	390,675
Weighted Average Exercise Price, Beginning Balance | $ / shares	$ 18.03
Weighted Average Exercise Price, Expired | $ / shares	0
Weighted Average Exercise Price, Ending Balance | $ / shares	$ 12.42
Weighted Average Contractual Life, Beginning Balance	6 months
Weighted Average Contractual Life, Ending Balance	5 months 15 days
Equity Classified Warrant [member]
Class of Warrant or Right [Line Items]
Number of Shares, Beginning Balance | shares	1,737,347
Number of Shares, Expired | shares	0
Number of Shares, Ending Balance | shares	1,737,347
Weighted Average Exercise Price, Beginning Balance | $ / shares	$ 31.83
Weighted Average Exercise Price, Expired | $ / shares	0
Weighted Average Exercise Price, Ending Balance | $ / shares	$ 31.83
Weighted Average Contractual Life, Beginning Balance	2 years 4 months 17 days
Weighted Average Contractual Life, Ending Balance	1 year 10 months 17 days

Warrants - Schedule Of Fair Val

Warrants - Schedule Of Fair Value Of Warrant Liability (Detail) - Liability Classified Warrant [member] - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Jun. 30, 2024
Class of Warrant or Right [Line Items]
Warrants Outstanding	1,997,208	390,675
Warrant Liability	$ 3,117	$ 1,583
Change in Fair value of warrants liability	(1,534)
Private Placement Financing Warrants [member]
Class of Warrant or Right [Line Items]
Strike Price		$ 19.39
Warrants Outstanding		0
Warrant Liability	1,673	$ 0
Change in Fair value of warrants liability	(1,673)
Modification Warrants [member]
Class of Warrant or Right [Line Items]
Strike Price		$ 12.04
Warrants Outstanding		316,947
Warrant Liability	1,151	$ 1,280
Change in Fair value of warrants liability	129
Additional Modification Warrants [member]
Class of Warrant or Right [Line Items]
Strike Price		$ 14.03
Warrants Outstanding		73,728
Warrant Liability	293	$ 303
Change in Fair value of warrants liability	$ 10

Warrants - Additional Informati

Warrants - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Class of Warrant or Right [Line Items]
Fair Value Adjustment of Warrants	$ 3,641	$ 621	$ 1,534	$ 2,263

Warrants - Schedule Of Fair V_2

Warrants - Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Warrant Liability (Detail) - Liability Classified Warrant [member]	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Volatility | Minimum [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.7481	0.6176
Volatility | Maximum [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.7997	0.7431
Remaining Term | Minimum [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding measurement Input term	4 months 9 days	4 months 20 days
Remaining Term | Maximum [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding measurement Input term	10 months 20 days	1 year 4 months 20 days
Risk Free Rate | Minimum [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.0402	0.0391

Warrants - Fair Value Of The Eq

Warrants - Fair Value Of The Equity Classified Warrants (Detail) - Equity Classified Warrant [member] - USD ($) $ / shares in Units, $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Class of Warrant or Right [Line Items]
Warrants Outstanding	1,737,347	1,737,347
Warrant Liability	$ 25,056	$ 25,056
Dispensary Mortgage Warrants [member]
Class of Warrant or Right [Line Items]
Strike Price	$ 9.1
Warrants Outstanding	35,000
Warrant Liability	$ 181	181
Private Placement Refinance Warrants April 2021 [Member]
Class of Warrant or Right [Line Items]
Strike Price	$ 32.68
Warrants Outstanding	1,459,044
Warrant Liability	$ 22,259	22,259
Private Placement Refinance Warrants October 2021 [Member]
Class of Warrant or Right [Line Items]
Strike Price	$ 30.02
Warrants Outstanding	243,303
Warrant Liability	$ 2,616	$ 2,616

Warrants - Schedule Of Fair V_3

Warrants - Schedule Of Fair Value Measurement Inputs and Valuation Techniques Used In Determining Equity Classified Warrants (Detail) - Equity Classified Warrant [Member]	6 Months Ended
	Jun. 30, 2024
Private Placement Refinance Warrants October 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant issuance date	Oct. 15, 2021
Private Placement Refinance Warrants April 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant issuance date	Apr. 30, 2021
Dispensary Mortgage Warrants [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant issuance date	Jun. 05, 2020
Volatility | Private Placement Refinance Warrants October 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.73
Volatility | Private Placement Refinance Warrants April 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.73
Volatility | Dispensary Mortgage Warrants [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.80
Remaining Term | Private Placement Refinance Warrants October 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding measurement Input term	4 years
Remaining Term | Private Placement Refinance Warrants April 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding measurement Input term	4 years
Remaining Term | Dispensary Mortgage Warrants [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding measurement Input term	5 years
Risk Free Rate | Private Placement Refinance Warrants October 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.0112
Risk Free Rate | Private Placement Refinance Warrants April 2021 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.0074
Risk Free Rate | Dispensary Mortgage Warrants [member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.0037

Share Capital - Schedule of Com

Share Capital - Schedule of Common Stock Outstanding Roll Forward (Detail)	6 Months Ended
	Jun. 30, 2024 shares
Subordinate Voting Shares [Member]
Class of Stock [Line Items]
Beginning balance	209,871,792
Ending balance	211,129,419
Subordinate Voting Shares [Member] | Share Capital [Member]
Class of Stock [Line Items]
Beginning balance	209,871,792
Distribution of contingent consideration	1,250,000
Issuance of shares upon exercise of options	843,387
Issuances of shares upon vesting of RSUs	804,440
Repurchase of Subordinate Voting Shares	(2,725,000)
Exchange of shares	1,084,800
Ending balance	211,129,419
Multiple Voting Shares [Member]
Class of Stock [Line Items]
Beginning balance	38,531
Ending balance	37,683
Multiple Voting Shares [Member] | Share Capital [Member]
Class of Stock [Line Items]
Beginning balance	38,531
Exchange of shares	(848)
Ending balance	37,683
Super Voting Shares [Member]
Class of Stock [Line Items]
Beginning balance	216,690
Ending balance	206,690
Super Voting Shares [Member] | Share Capital [Member]
Class of Stock [Line Items]
Beginning balance	216,690
Exchange of shares	(10,000)
Ending balance	206,690

Share Capital - Share-based Pay

Share Capital - Share-based Payment Arrangement, Option, Activity (Detail) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Shares, Balance	10,071,467
Number of Share, Granted	797,289
Number of Shares, Exercised	(843,387)
Number of Shares, Forfeited	(828,488)
Number of Shares, Ending Balance	9,196,881	10,071,467
Number of Share, Exercisable	4,214,462
Weighted Average Exercise Price, Balance	$ 11.75
Weighted Average Exercise Price, Granted	14.96
Weighted Average Exercise Price, Exercised	8.81
Weighted Average Exercise Price, Forfeited	14.06
Weighted Average Exercise Price, Ending Balance	12.44	$ 11.75
Weighted Average Exercise Price, Exercisable	$ 8
Weighted Average Contractual Life, Balance	4 years 4 months 28 days	4 years 3 months 21 days
Weighted Average Contractual Life, Exercisable	3 years 9 months 10 days

Share Capital - Schedule of Sha

Share Capital - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Detail)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Risk-free interest rate, Minumum	3.25%	3.06%
Risk-free interest rate, Maximum	3.92%	4.32%
Expected dividend yield	0%	0%
Expected volatility	62%	64%
Minimum [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Expected option life	4 years 5 months 15 days	3 years 6 months
Maximum [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Expected volatility	64%
Expected option life	4 years 6 months	4 years 6 months

Share Capital - Non-vested Rest

Share Capital - Non-vested Restricted Stock Shares Activity (Detail)	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Shares, Balance | shares	3,620,638
Number of Shares, Granted | shares	2,458,964
Number of Shares, Forfeited | shares	(609,639)
Number of Shares, Vested | shares	(804,440)
Number of Shares, Balance | shares	4,665,523
Weighted Average Grant Date Fair Value, Balance | $ / shares	$ 9.25
Weighted Average Grant Date Fair Value, Granted | $ / shares	14.75
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	11.29
Weighted Average Grant Date Fair Value, Vested | $ / shares	9.89
Weighted Average Grant Date Fair Value, Balance | $ / shares	$ 11.88

Share Capital - Schedule of Sto

Share Capital - Schedule of Stock-Based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-Based Compensation Expense	$ 8,866	$ 7,381	$ 15,356	$ 13,620
Stock options expense
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-Based Compensation Expense	2,637	4,303	5,694	8,786
Restricted Stock Units
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-Based Compensation Expense	$ 6,229	$ 3,078	$ 9,662	$ 4,834

Share Capital - Additional Info

Share Capital - Additional Information (Detail) $ / shares in Units, $ in Thousands				3 Months Ended		6 Months Ended
	Feb. 15, 2024 USD ($)	Feb. 09, 2024 shares	Jun. 01, 2018	Jun. 30, 2024 USD ($) shares	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) Dispensary $ / shares shares	Jun. 30, 2023 USD ($)	Sep. 05, 2023 USD ($) shares
Selling, General and Administrative Expense				$ 96,500	$ 84,217	$ 170,758	$ 164,736
Dharma Pharmaceuticals LLC [Member]
Conversion of Stock, Shares Issued | shares		1,250,000				65,000,000
Selling, General and Administrative Expense	$ 15,991
Dharma Pharmaceuticals LLC [Member] | Maximum [Member]
Retail dispensary | Dispensary						5
Restricted Stock Units (RSUs) [Member]
Cost Not yet Recognized, Amount				$ 63,591		$ 63,591
Cost Not yet Recognized, Period for Recognition						2 years 2 months 15 days
Multiple Voting Shares [Member] | Conversion Of Multiple Voting Shares [member]
Voting Rights						100
Subordinate Voting Shares [Member] | Dharma Pharmaceuticals LLC [Member]
Issuance of shares under business combinations and investments, value	$ 17,259
Subordinate Voting Shares [Member] | GTII Stock and Incentive Plan [Member]
Percentage of maximum number of shares issued under the plan			10%
Super Voting Shares [Member] | Conversion Of Super Voting Shares [member]
Voting Rights						1,000
Repurchase of Subordinate Voting Shares[Member]
Percentage of Stock Repurchase Program, Authorized								5%
Share Repurchase Program, Authorized, Number of Shares | shares				2,725,000		2,725,000		10,486,951
Accelerated Share Repurchases, Final Price Paid Per Share | $ / shares						$ 12.27
Share Repurchase Program, Remaining Authorized, Amount				$ 26,700		$ 26,700
Share Repurchase Program, Authorized, Amount								$ 50,000

Income Tax Expense - Schedule o

Income Tax Expense - Schedule of Components of Income Tax Expense (Benefit) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]
Income before Income Taxes	$ 52,817	$ 39,455	$ 116,314	$ 82,496
Income Tax Expense	$ 31,899	$ 25,765	$ 64,048	$ 59,401
Effective Tax Rate	60.40%	65.30%	55.10%	72%

Income Tax Expense - Additional

Income Tax Expense - Additional Information (Detail) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Income tax paid	$ 52,904	$ 52,134

Other Income (Expense) - Schedu

Other Income (Expense) - Schedule of Other Nonoperating Income (Expense) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Fair value adjustments on equity investments	$ (472)	$ (655)	$ 167	$ (1,134)
Fair value adjustment on warrants issued	3,641	621	1,534	2,263
Loss from equity method investments	(772)	(432)	(1,100)	(750)
Other	67	196	100	275
Total Other Income (Expense)	$ 2,464	$ (270)	$ 701	$ 654

Commitments and Contingencies -

Commitments and Contingencies - Additional of Information (Detail) $ in Thousands	1 Months Ended	6 Months Ended	12 Months Ended
	Aug. 01, 2024 USD ($)	Jun. 30, 2024 USD ($) Lawsuit	Dec. 31, 2023 Lawsuit
Subsequent Event [Member]
Disclosure of Commitments and Contingencies [Line Items]
Loss contingency, damages sought, value	$ 7,307
Construction Commitments [Member]
Disclosure of Commitments and Contingencies [Line Items]
Contractual obligation		$ 5,400
Pending Litigation [Member]
Disclosure of Commitments and Contingencies [Line Items]
Loss contingency, number of plaintiffs | Lawsuit		0	0

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Measurements, Recurring and Nonrecurring (Detail) - Financial Instruments [Member] - USD ($) $ in Thousands	Jun. 30, 2024	Jun. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	$ 196,142	$ 161,634
Investments	61,412	64,361
Contingent Consideration Payable		(33,250)
Warrant Liability	(1,583)	(3,117)
Fair Value, Net Asset (Liability)	255,971	189,628
Fair Value, Inputs, Level 1 [member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	196,142	161,634
Investments	24,695	24,215
Contingent Consideration Payable		0
Warrant Liability	0	0
Fair Value, Net Asset (Liability)	220,837	185,849
Fair Value, Inputs, Level 2 [member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	0
Investments	0	0
Contingent Consideration Payable		0
Warrant Liability	0	0
Fair Value, Net Asset (Liability)	0	0
Fair Value, Inputs, Level 3 [member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	0
Investments	36,717	40,146
Contingent Consideration Payable		(33,250)
Warrant Liability	(1,583)	(3,117)
Fair Value, Net Asset (Liability)	$ 35,134	$ 3,779

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Disclosure Text Block Supplement [Abstract]
Notes payable	$ 309,743	$ 308,523
Current Portion of Notes Payable	$ 227,265	$ 2,996

Segment Reporting - Schedule of

Segment Reporting - Schedule of Revenues (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Segment Reporting Information [Line Items]
Revenues	$ 280,147	$ 252,388	$ 555,953	$ 500,924
Depreciation and Amortization	27,985	24,234	55,760	47,735
Income Taxes	31,899	25,765	64,048	59,401
Operating Segments [Member] | Consumer Packaged Goods Segment [Member]
Segment Reporting Information [Line Items]
Revenues	156,323	136,054	306,235	261,671
Depreciation and Amortization	17,549	15,125	35,077	29,794
Income Taxes	15,494	12,437	30,079	27,062
Operating Segments [Member] | Retail Segment [Member]
Segment Reporting Information [Line Items]
Revenues	204,656	188,044	408,434	376,922
Depreciation and Amortization	10,436	9,109	20,683	17,941
Income Taxes	16,405	13,328	33,969	32,339
Operating Segments [Member] | Intersegment Eliminations and Corporate [Member]
Segment Reporting Information [Line Items]
Revenues	(80,832)	(71,710)	(158,716)	(137,669)
Depreciation and Amortization	0	0	0	0
Income Taxes	$ 0	$ 0	$ 0	$ 0

Segment Reporting - Additional

Segment Reporting - Additional Information (Detail) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Goodwill	$ 589,691	$ 589,691
Intangible Assets Net	513,434	538,678
Consumer Packaged Goods Segment [Member]
Goodwill	315,889	315,889
Retail Segment [Member]
Goodwill	273,802	273,802
Operating Segments [Member] | Consumer Packaged Goods Segment [Member]
Goodwill	315,889	315,889
Intangible Assets Net	247,011	260,186
Operating Segments [Member] | Retail Segment [Member]
Goodwill	273,802	273,802
Intangible Assets Net	$ 266,423	$ 278,492